NCT01237990 Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures Status COMPLETED Phase N/A
NCT01230697 Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM) Status UNKNOWN Phase N/A
NCT01219985 Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver Status COMPLETED Phase NA
NCT01213030 Clinical Evaluation of the New Hypoxia Imaging Agent HX4 Status COMPLETED Phase PHASE1/PHASE2
NCT01210027 A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion Status COMPLETED Phase N/A
NCT01185639 Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase NA
NCT01182272 Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery Status UNKNOWN Phase PHASE2
NCT01180959 Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy Status COMPLETED Phase PHASE2
NCT01171924 A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors Status COMPLETED Phase PHASE1
NCT01164202 Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01151761 Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation Status TERMINATED Phase PHASE2
NCT01099631 IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread Status COMPLETED Phase PHASE1
NCT01082224 Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy Status UNKNOWN Phase NA
NCT01079767 Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis Status TERMINATED Phase PHASE2
NCT01076517 A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma Status APPROVED_FOR_MARKETING Phase N/A
NCT01075555 Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis Status COMPLETED Phase PHASE3
NCT01075399 Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors Status COMPLETED Phase PHASE2
NCT01075113 Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer Status COMPLETED Phase PHASE1
NCT01071434 Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors Status TERMINATED Phase N/A